Mixed lineage kinase 2 (MLK2) is a protein kinase that signals in the stress-activated Jun N-terminal kinase signal transduction pathway. We used immunoprecipitation and mass spectrometric analysis to identify MLK2-binding proteins in cell lines with inducible expression of green fluorescent protein-tagged MLK2. Here we report the identification of clathrin as a binding partner for MLK2 in both cultured cells and mammalian brain. We demonstrate that clathrin binding requires a motif (LLDMD) located near the MLK2 C terminus, which is similar to "clathrin box" motifs important for binding of clathrin coat assembly and accessory proteins to the clathrin heavy chain. A C-terminal fragment of MLK2 containing this motif binds strongly to clathrin, and mutation of the LLDMD sequence to LAAAD completely abrogates clathrin binding. We isolated clathrin-coated vesicles from green fluorescent protein-MLK2-expressing cells and from mouse brain lysates and found that MLK2 is enriched along with clathrin in these vesicles. In addition, we demonstrated that endogenous MLK2 co-immunoprecipitates with clathrin heavy chain from the vesicle-enriched fraction of mouse brain lysate. Furthermore, overexpression of MLK2 in cultured cells inhibits accumulation of labeled transferrin in recycling endosomes during receptor-mediated endocytosis. These findings suggest a role for MLK2 and the stress-signaling pathway at sites of clathrin activity in vesicle formation or trafficking.
The mixed lineage kinases (MLKs) 1 (1) are a family of protein kinases that activate the stress-activated protein kinase cascade leading to phosphorylation of transcription factor cJun by the Jun N-terminal kinase (JNK) (2, 3) . Like other mitogen-activated protein kinases, JNK is the final member of a three-kinase cascade in which sequential phosphorylation events transmit signals from upstream activators to the nucleus to initiate gene transcription (4) . JNKs are activated by dual phosphorylation on threonine and tyrosine by MAP kinase kinases (MAP2Ks), MKK4 and MKK7, that are in turn activated by a number of MAP3Ks including MLK family members (2, 3, 5) . The three sequential kinases in a given cascade form a signaling module that responds to a specific set of stimuli to initiate cellular events. In addition to transcription factors, JNKs phosphorylate a diverse range of proteins (6 -8) and play significant roles in many cellular functions including proliferation and differentiation, inflammatory and immune responses, cell cycle arrest, and apoptosis (4, 9, 10) .
In mammalian cells, there are three closely related MLK family members (MLKs 1-3) (1, 11, 12) as well as two more distantly related members (DLK/ZPK and LZK) (13) (14) (15) . MLKs 1-3 each contain a set of highly conserved structural domains associated with protein interactions and signal transduction including an Src homology 3 (SH3) domain (16) , a kinase catalytic domain, two leucine zipper (LeuZip) motifs (17) , a basic peptide, and a Cdc42/Rac interactive binding (CRIB) motif (18) . In addition, each has a unique N-terminal peptide and a large C-terminal domain rich in serine, threonine, and proline but with reduced amino acid similarity among the three proteins. The more distantly related members retain much of the overall MLK family structure but lack an SH3 domain and share a lower level of amino acid conservation with MLKs 1-3. Although all are activators of the stress-signaling pathway, little is known about their modes of activation, and their physiological roles in mammalian cells are just beginning to be revealed.
One of the MLK proteins, MLK2, is expressed at high levels in human brain, skeletal muscle, and testis (11, 19) ; however, it is present at low levels in many human epithelial cell lines, and searches of EST data bases reveal a wide distribution in embryonic and adult human tissues. Past studies (20 -23) have identified MLK2 interactions with proteins involved in regulation of membrane and cytoskeletal changes during cellular activation, cell contact, and vesicle formation. These include tubulin (21) and microtubule motor proteins (20) as well as actin-regulating GTPases, Cdc42, and Rac that bind the MLK2-CRIB motif in a GTP-dependent manner (18, 20) . MLK2 also binds to PSD95 (22) , a member of the membrane-associated guanylate kinase protein family involved in formation of multiprotein signaling complexes at synapses, cellular junctions, and polarized membrane domains (24) . PSD-95 anchors MLK2 to a complex with the kainate receptor, GluR6, in neuronal cells (22) , and expression of a dominant-negative MLK2 mutant (DN-MLK2) inhibits kainic acid signaling in this cellular system. Furthermore, the MLK2-SH3 domain binds to and activates the GTPase, dynamin (23) , that is involved in vesicle formation during receptor-mediated endocytosis, neurotransmission, and Golgi transport (reviewed in Ref. 25) . Interestingly, Cdc42 and Rac also regulate endocytic traffic (Refs. 26 and 27 reviewed in Ref. 28) , most likely through actin rearrangement at sites of clathrin-coated vesicle formation (29) .
Further interaction studies reveal that the three members of the MLK to JNK signaling module, MLKs 2, 3, or DLK, together with MKK7 and JNK, bind a set of scaffold proteins, JNK-interacting proteins (JIPs) (30) . The JIP scaffolding interactions serve to modulate, and possibly direct, signaling within the MLK/JNK cascade (30, 31) . JIPs also bind apoER2, the neuronal receptor for reelin (32) , a molecule required for correct positioning of neurons during development. In addition, JIPs bind kinesin motor proteins, and a complex of kinesin, JIP, DLK, and apoER2 can be precipitated by addition of stabilized microtubules to a high speed supernatant fraction of rat brain lysate (33) . These results led to the suggestion that the DLK-MKK7-JNK signaling module is pre-assembled onto JIP together with an apoER2-containing vesicle and that the entire complex is transported along microtubules to potential sites of activity. A separate study of the JIP-DLK interaction revealed that JIP binding holds DLK in an inactive monomeric form and that upon release from JIP, DLK dimerizes, thereby becoming active (34) . Thus, vesicle transport and receptor signaling activities can be coordinated through scaffold interactions of the MLK-JNK signaling module with JIP. However, the exact functional outcome of this coordination remains to be defined.
Recently, we established a role for MLK2 in stress-related apoptosis in neuronal cells. Thus, MLK2 activation of the JNK pathway is required for HN33 neuronal cell apoptosis in response to expression of glutamine-expanded huntingtin, the mutant product of the Huntington's disease gene (35) . The SH3 domain of MLK2 binds normal huntingtin protein, and the polyglutamine expansion associated with Huntington's disease blocks the interaction. Expression of DN-MLK2 inhibits the apoptotic response to mutated huntingtin in these cells. As MLK2 expression is not limited to neuronal cells, it is likely to have functional roles in a number of biologically relevant settings. To identify such roles for MLK2 in mammalian cells, we created cell lines with inducible expression of GFP-tagged MLK2. We report here that MLK2 binds to clathrin heavy chain (CHC) and is enriched in clathrin-coated vesicles (CCVs) in cultured cells and in murine brain. In addition, overexpression of MLK2 in cultured cells inhibits endocytic function. Taken together with previous findings of MLK2 interactions with endocytic regulators (20 -23) and involvement of MLK family members in JIP-kinesin complexes with microtubules (33), the MLK2-clathrin interaction suggests a role for MLK2 at sites of clathrin activity in vesicle trafficking.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies-Dulbecco's modified Eagle's medium (DMEM), leupeptin, pepstatin, and aprotinin were from ICN. Fetal calf serum was from the Commonwealth Serum Laboratories (Parkville, Australia) and gentamycin from David Bull Laboratories (Melbourne, Australia). Polyclonal anti-MLK2 antibodies were raised in sheep against a recombinant protein containing amino acids 1-100 of human MLK2 (11) and affinity-purified using a MLK2-(1-100)-glutathione Stransferase fusion protein bound to GSH beads. For immunoblotting, anti-MLK2 antibodies were used with biotinylated rabbit anti-goat immunoglobulin secondary antibodies from Dako Australia (Botany, New South Wales, Australia). Rabbit anti-GFP antibodies and Texas Red-conjugated transferrin were from Molecular Probes (Eugene, OR); mouse anti-CHC, anti-␣-adaptin (AP-2), and anti-␥-adaptin (AP-1) antibodies were from Transduction Laboratories, and Texas Red-conjugated goat anti-mouse immunoglobulin antibodies were from Sigma. Biotinylated sheep anti-mouse and goat anti-rabbit immunoglobulin antibodies, streptavidin-biotin conjugated alkaline phosphatase, and Hybond C Super nitrocellulose membranes were from Amersham Biosciences. Alkaline phosphatase substrate reagent, 5-bromo-4-chloro-3-indolylphosphate, was from Roche Molecular Biochemicals, and nitro blue tetrazolium was from Sigma. FuGENE TM 6 transfection reagent was also from Roche Molecular Biochemicals, and protein A-Sepharose was from Amersham Biosciences. Vectashield mounting medium was from Vector Laboratories (Burlingame, CA).
Plasmids-cDNAs containing the complete human MLK2 proteincoding region (nucleotides 289 -3454, including an in-frame stop codon beginning at nucleotide 3151 (11)), the N-terminal region (N-MLK2, nucleotides 289 -1777), the C-terminal region (C-MLK2, nucleotides 1778 -3454), and the C-terminal 321 nucleotides (C100-MLK2, nucleotides 2830 -3154) were cloned into the vector pEGFPC1 (CLONTECH). For production of tetracycline-inducible cell lines, GFP-MLK2 was subcloned into vector pTRE (CLONTECH) and co-transfected with a modified Tet-ON (CLONTECH) vector (pEFpuropTet-ON (36)) with tetracycline-inducible expression driven by the EF-1 promoter and a gene for puromycin resistance. The pEFpuropTet-ON vector was constructed by Dr. G. Vairo (Walter and Eliza Hall Institute, Melbourne, Australia) and was a gift from Dr. H.-J. Zhu (Ludwig Institute, Melbourne, Australia). Kinase-negative MLK2 mutant, K125A-MLK2 (DN-MLK2) was made using the Altered Sites II in vitro mutagenesis kit (Promega) essentially according to the manufacturer's instructions, as described previously (19) . The clathrin box mutant, 932 
LDM
934 f AAA C100A3-MLK2 was made by PCR-based mutagenesis.
Cell Culture and Transfection-HEK-293 cells were maintained in DMEM supplemented with 10% fetal calf serum and 20 g/ml (20 IU) gentamycin at 37°C in 5% CO 2 in air. For transient expression, cells (0.5-1 ϫ 10 6 ) were transfected with 2-5 g of plasmid DNA using FuGENE 6 TM transfection reagent and lysed for assay 24 h later. For GFP-stable transfectants, cells were transfected with 5 g of plasmid DNA and grown in the presence of 400 g/ml G418 antibiotic. Clones of resistant cells were isolated and assayed by microscopy for expression of the GFP fusion protein and by immunoblotting with anti-GFP antibodies to confirm the size of the expressed protein. Tet-ON lines were made by co-transfecting pEFpuropTet-ON vector together with a 10-fold excess of GFP-MLK2 pTRE into HEK-293 cells, and the cells were grown in the presence of 2 g/ml puromycin. Resistant cells were cloned, and individual clones were selected for expression of correctly sized GFP fusion proteins following induction with 2 g/ml doxycycline.
Protein Isolation and Mass Spectrometry-GFP-MLK2 was immunoprecipitated with anti-GFP antibodies from untreated or doxycyclinetreated (2 g/ml, 24 h) GFP-MLK2-Tet-ON cells using anti-GFP antibody. Precipitated proteins were separated by SDS-PAGE on a 4 -20% acrylamide gradient gel (NOVEX) and visualized by fast Coomassie Blue staining (37) . Protein bands were excised and digested in situ with 0.5 g of trypsin as described previously (38, 39) .
An electrospray ion trap mass spectrometer (model LCQ; Finnigan, San Jose, CA) coupled on-line with a capillary high pressure liquid chromatography was used for peptide sequencing (38, 39) . Electrospray ionization parameters are as follows: spray voltage, 4.5 kV; sheath and auxiliary gas flow rates, 30 and 5 arbitrary values, respectively; capillary temperature, 150°C; capillary voltage, 20 V; tube lens offset, 16 V. The sheath liquid was 2-methoxyethanol (99.9% high pressure liquid chromatography grade) delivered at a flow rate of 3 l/min. The electron multiplier was set to 860 V. The ion trap automatic gain control parameter was turned on for all experiments, and this, coupled with a maximum injection time of 200 ms, ensured that the number of ions in the trap was automatically maintained at a constant preset value. All data were collected in centroid mode using a "triple play" experiment. After acquisition of a full mass spectrometry (MS) scan (350 -2000 Da) in the first scan event, the most intense ion present above a preset threshold of 1 ϫ 10 5 counts was isolated. In the second and third scan events, a high resolution (Zoom) scan and a collision-induced dissociation tandem mass spectrometry (MS/MS) scan of the selected ion were performed. The collision energy for the MS/MS scan events was preset at a value of 55%.
Mass Spectrometric Data Analysis-The sequences of uninterpreted collision-induced dissociation spectra were identified by correlation with peptide sequences present in a non-redundant protein sequence data base (comprising ϳ849,000 entries) using the SEQUEST algorithm (version 27, revision 11) incorporated into the Finnigan-BioBrowser TM software (version 2.0). The SEQUEST search results were assessed by examination of the Xcorr (cross-correlation) and Cn (normalized correlation) scores. Manual inspection of each spectrum was performed to confirm the SEQUEST result.
Immune Precipitation and Blotting-Cells were washed in phosphate-buffered saline and lysed in ice-cold lysis buffer (50 mM HEPES, pH 7.2, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EGTA, 1.5 mM MgCl 2 , 50 mM NaPO 4 , 5 mM dithiothreitol with the following protease inhibitors: 1 mM phenylmethylsulfonyl fluoride and 1 g/ml each aprotinin, leupeptin, and pepstatin). Lysates were incubated on ice for 10 min and then clarified by centrifugation at 13,000 rpm, 4°C in a microcentrifuge. Clarified lysate protein concentrations were determined using the bicinchoninic acid assay (40) , and protein concentrations were equalized for immune precipitation or immunoblotting. For immune precipitation, primary antibodies were added 1 h prior to addition of protein A-Sepharose (or a mixture of protein A-Sepharose and protein G-Sepharose in the case of anti-clathrin immune precipitation), and the mixture was incubated overnight at 4°C on a rotating wheel. Sepharose beads were washed three times in lysis buffer and resuspended in SDS-PAGE sample buffer. Immune precipitates or aliquots of cellular lysate containing 30 -50 g of protein were subjected to SDS-PAGE and transferred to nitrocellulose for immunoblotting.
Isolation of Clathrin-coated Vesicles-CCVs were isolated from cultured cells as described by Metzler et al. (67) . Briefly, 8 ϫ 10 7 cells were homogenized in 3 ml of ice-cold buffer A (0.1 M MES, pH 6.5, 1 mM EGTA, 0.5 mM MgCl 2 with protease inhibitors, as above) on ice using a glass Dounce homogenizer (10 strokes; fraction H). All subsequent steps were performed on ice or at 4°C. The homogenate was clarified by centrifugation at 17,800 ϫ g for 20 min, and the supernatant was collected and centrifuged at 56,100 ϫ g for 1 h. The pellet from the second centrifugation was resuspended in 500 l of buffer A, loaded onto buffer A containing 8% sucrose, and centrifuged (115,800 ϫ g, 2 h). The supernatant was removed, and the final pellet containing CCVs was resuspended in 30 l of buffer A (fraction SGP). Equal amounts of protein from SGP fractions were analyzed by SDS-PAGE.
CCVs were isolated from mouse brain essentially following the procedure of Maycox et al. (41) , with minor modifications. Briefly, 10 mouse brains were homogenized in 20 ml of cold buffer A using a glass homogenizer (10 strokes; fraction H) with subsequent steps on ice or at 4°C. The homogenate was centrifuged at 20,000 ϫ g for 20 min. The pellet was resuspended in 5 ml of buffer A (fraction P1), and the supernatant (fraction S1) was centrifuged at 55,000 ϫ g for 1 h. The supernatant was drained, and the pellet was resuspended in 1.2 ml of buffer A and homogenized as above (three strokes) followed by dispersion through a 26-gauge needle. The suspension (fraction P2) was then mixed with 1.2 ml of buffer A containing 12.5% Ficoll and 12.5% sucrose and centrifuged (40,000 ϫ g, 40 min). The supernatant was diluted to 3.9 ml in buffer A and centrifuged (100,000 ϫ g, 1 h) to pellet the vesicles. The supernatant was drained, and the pellet was resuspended in 1.0 ml of buffer A and dispersed through a 26-gauge needle. This suspension was cleared by centrifugation (20,000 ϫ g, 20 min), and the pellet was resuspended in 100 l of buffer A (fraction P4). The supernatant was layered on top of buffer A containing 8% sucrose and centrifuged for 2 h at 115,800 ϫ g. The supernatant (fraction S4) was drained, and the final pellet was resuspended in 70 l of buffer A (fraction SGP). Equal amounts of protein from fractions were analyzed by immunoblotting with anti-CHC, anti-MLK2, or anti-Myc tag (nonspecific) antibodies.
Transferrin Uptake-Cells were plated onto poly-L-lysine-coated glass coverslips at a density of 1.5 ϫ 10 6 cells/90-mm tissue culture plate, transfected as described above, and serum-starved overnight. Cells were then incubated with 25 g/ml Texas Red-conjugated human transferrin in DMEM for 20 min, washed briefly in phosphate-buffered saline, and fixed for 10 min in 4% paraformaldehyde in PME buffer (100 mM Pipes, pH 6.9, 5 mM MgSO 4 , 10 mM EGTA, and 2 mM dithiothreitol). Cells with significant internal clustering of transferrin in recycling endosomes were counted using a Zeiss Axioskop 2 fluorescence microscope as follows: each coverslip was divided into quadrants, and 100 transfected cells (25 per quadrant) were evaluated for extent of transferrin clustering. Cells were scored as positive if significant clustering of transferrin was present and negative if only punctate distribution of red fluorescence was observed. Untransfected or transfected cells were counted on 6 independent coverslips (600 cells total) per expression construct.
RESULTS
Clathrin Is an MLK2-binding Partner-Although we (21) (22) (23) 35) and others (18, 20) have previously identified MLK2 interactions with proteins involved in cytoskeletal rearrangement or vesicle trafficking, the nature of MLK2 function in these systems has not been revealed. It is clear that MLK2, like many of the proteins with which it interacts, has the ability to participate in a range of different multiprotein complexes. To identify interactions that may shed light on how MLK2 functions in these systems, we made cell lines with inducible expression of GFP-tagged MLK2. We used these cells with a combination of immunoprecipitation and mass spectrometric methods to identify members of protein complexes involving MLK2. When SDS-PAGE profiles of proteins in anti-GFP immune precipitates from GFP-MLK2 expressing and non-expressing cells were compared (Fig. 1) , several protein bands appeared only in the presence of GFP-MLK2. In addition to GFP-MLK2 itself (band 2), most notable are a 150 -200-kDa protein (band 1) and a low molecular mass protein (band 3).
Mass spectrometric analysis confirmed that the most abundant protein (band 2) was GFP-MLK2. The larger molecular mass band (band 1) was identified as human CHC with 45 matching tryptic peptides covering 35% of the CHC amino acid sequence. Protein band 3 was identified as the epsilon isoform of the 14.3.3 signaling adapter protein (9 tryptic peptides, 61% sequence coverage). As 14.3.3⑀ has been reported previously as an MLK2-binding protein in a yeast two-hybrid screen (20) , its presence in the GFP-MLK2 immunoprecipitate supported the validity of the identification approach and pointed to clathrin as a potential MLK2-binding partner. Several other protein bands from this gel were later excised and sequenced (data not shown) revealing the presence of small amounts of 14.3.3 isoforms /␦ and ␥ as well as a number of truncated forms of GFP-MLK2 (data not shown).
To confirm that binding of clathrin was specific for MLK2 and did not involve the GFP fusion partner, we used anti-CHC antibodies to immunoprecipitate clathrin from lysates of the Tet-ON GFP-MLK2-expressing cells. As a control we used lysates of HEK-293 cells stably expressing GFP alone. Immunoblotting of the precipitated proteins with anti-GFP antibodies ( Fig. 2A) clearly showed that GFP-MLK2 is present in the anti-CHC immunoprecipitate, whereas GFP alone is not. Similarly, when anti-GFP immunoprecipitates from Tet-ON cells either untreated or induced to express GFP-MLK2 or cells expressing GFP alone were probed with anti-CHC antibodies (Fig. 2B) , CHC was specifically precipitated with the GFP-MLK2 but not with GFP.
MLK2 Binds Clathrin through a Clathrin Box Motif-Once specificity of the MLK2-clathrin interaction was confirmed, we sought to determine which region of the MLK2 protein is involved in clathrin binding. The domain structure of the MLK2 protein (11) is shown in Fig. 3A along with that of a series of MLK2 truncation mutants used for this study. The MLK2 N-terminal region (aa 1-496; N-MLK2) contains the SH3, kinase catalytic and double leucine zipper (LeuZip) domains, as well as a basic peptide and the CRIB motif. The C-terminal region of the protein (aa 497-954; C-MLK2) contains no known structural domains but has several proline-rich peptides conforming to consensus SH3-binding motifs (42, 43 ) and a 14.3.3 recognition motif (44) . Initially, we transiently transfected HEK-293 cells with expression vectors for GFP-(full-length)-MLK2, GFP-N-MLK2 or GFP-C-MLK2. Anti-GFP immune precipitates from lysates of these cells were blotted with anti-CHC antibodies (Fig. 3B) . Clathrin interacted strongly with sequences within both GFP-(full-length)-MLK2 and GFP-C-MLK2, but not GFP-N-MLK2, clearly demonstrating that the clathrin-binding site is located in the C-terminal region of the MLK2 protein.
Examination of the MLK2 C-terminal region amino acid sequence (11) revealed the presence of a sequence ( 931 LL-DMD 935 ) similar to the clathrin box motifs (Fig. 3C ) important for binding of a number of endocytic proteins to CHC (45) (46) (47) . To determine whether this peptide is a clathrin recognition motif, we constructed a vector that encodes a GFP fusion with the C-terminal 107 amino acids of MLK2 (aa 848 -954; GFP-C100-MLK2), including the LLDMD sequence. In addition, we constructed a mutant cDNA encoding GFP-C100-MLK2 in which three amino acids within the putative clathrin box motif ( 932 LDM 934 ) were replaced by alanines (GFP-C100A3-MLK2). GFP-C100-MLK2, GFP-C100A3-MLK2, or GFP alone were transiently expressed in HEK-293 cells and immunoprecipitated from cell lysates with anti-GFP antibodies. Anti-CHC immunoblots of the immunoprecipitated proteins (Fig. 3D) revealed that CHC was readily precipitated with GFP-C100-MLK2 but not with GFP-C100A3-MLK2 or GFP alone.
Another motif found in clathrin-binding endocytic accessory proteins, including epsins and auxillin, is a tripeptide, (D/N)-P(W/F), that forms a binding site for clathrin assembly proteins (APs) (48) . The APs are heterotetramers that participate in clathrin coat assembly at specific subcellular locations, AP-2 and AP180 at the plasma membrane (49) and APs-1 and 3 at the trans-Golgi and endosomes (50) . In the epsins, multiple copies of the tripeptide motif are arrayed near the clathrin box motif, whereas auxillin has three copies within a clathrinbinding region (45, 47) . Binding of the DPW region of epsin to AP-2 enhances the AP-2/clathrin interaction important for clathrin coat assembly (45) . In the MLK2 protein, a single DPW motif is located in the C-terminal region (aa 897-899) beginning 34 residues N-terminal to the LLDMD sequence. We therefore analyzed anti-GFP immune precipitates from the GFP-MLK2 expressing Tet-ON cells for the presence of subunits of AP-1 (anti-␥-adaptin) or AP-2 (anti-␣-adaptin). However, we were unable to detect either of these APs among the proteins that co-precipitate with GFP-MLK2 (data not shown), a finding consistent with data from sequence analysis of proteins that co-immunoprecipitate with GFP-MLK2 from the same cells, in which no AP subunits were found.
GFP-MLK2 Localizes to CCVs-The co-immunoprecipitation experiments above confirmed that MLK2 binding to CHC is through a sequence similar to that utilized by a number of accessory proteins involved in formation of clathrin coats during vesicle budding (47) . We therefore examined whether MLK2 is present in CCVs isolated from Tet-ON cells expressing GFP-MLK2. For this, CCV-enriched pellets from sucrose gradient fractionations (see "Experimental Procedures") were subjected to immunoblotting with anti-CHC and anti-GFP antibodies (Fig. 4A) . In this analysis it was clear that when overexpressed in cultured cells, GFP-MLK2 is present along with clathrin in coated vesicle-enriched fractions. GFP, on the other hand, is found mainly in the supernatant fraction of the sucrose gradient (data not shown) with only a trace amount in the CCV-enriched pellet. The additional bands recognized by anti-GFP antibodies in the CCV-enriched pellet from GFP-MLK2-expressing cells represent truncated forms of MLK2 that are consistently present in SDS-PAGE analysis of these cells. Mass spectral analysis of the equivalent bands from anti-GFP immune precipitates of these cells revealed the presence of C-terminally truncated forms of MLK2 that co-immunoprecipitate with full-length GFP-MLK2 (data not shown). Like other MLK family members, MLK2 forms dimers through LeuZip interactions, 2 which accounts for the presence of these truncated forms along with full-length MLK2 in the CCVenriched fraction from these cells. 
Endogenous MLK2 Is Enriched in Murine Brain CCVs and
Co-immunoprecipitates with CCV-localized Clathrin-It is formally possible that the presence of GFP-MLK2 in CCVs isolated from the Tet-ON cell lines could be the result of mislocalization due to overexpression. Therefore, as endogenous MLK2 is expressed at high levels in the brain (11) where CCVs are also abundant, we examined the interaction of MLK2 with clathrin in this tissue. CCVs were prepared from homogenates of murine brain and CCV-containing fractions from several steps of the isolation procedure assayed for the presence of endogenous MLK2 and CHC (Fig. 4B) . This analysis showed clearly that endogenous MLK2 is enriched in the same fractions in which clathrin is most concentrated, and both MLK2 and CHC are highly enriched in the final CCV pellet (SGP). Interestingly, anti-MLK2 antibodies consistently detect a second band in immunoblots of CCV-rich fractions (Fig. 4B , fractions P4 and SGP) that migrates more slowly than MLK2, which appears just above the M r 116,000 marker in analysis of brain homogenates and early fractions from the CCV isolation (Fig. 4B, fractions H, S1, P1, and P2) . It is not clear whether the slower migrating band is a cross-reacting protein that co-fractionates with MLK2 in the vesicle purification or if a modified form of MLK2 is present in brain-derived CCVs.
To determine whether endogenous MLK2 complexes with clathrin in CCVs, we immunoprecipitated CHC from a CCVenriched fraction of the brain homogenate (see "Experimental Procedures"). The anti-CHC immune precipitates were then immunoblotted with anti-MLK2 antibodies (Fig. 4C) , and endogenous MLK2 was present as a doublet band in the anti-CHC immune precipitate (lane 3). When control antibodies were used in the immunoprecipitation reactions, clathrin tended to precipitate non-specifically from fractions where it was present in very high abundance (data not shown). However, a nonspecific antibody that failed to precipitate clathrin from fraction S4 of the CCV isolation also failed to precipitate MLK2 (Fig. 4C,   lane 1) . In addition, clathrin was immunoprecipitated from fraction S1 in which MLK2 is present at very low levels (see Fig. 4B , lane S1), and no cross-reacting proteins were detected in an anti-MLK2 blot of this fraction (data not shown). Therefore, results of both direct immunoblotting and immunoprecipitation studies show clearly that endogenous MLK2 complexes and co-precipitates with clathrin in CCV-rich fractions from mammalian brain.
MLK2 Influences Endocytosis-Interaction of MLK2 with clathrin in CCVs indicates a possible role in endocytosis or vesicle trafficking. To ask whether MLK2 plays a role in endocytic function, cells transiently expressing GFP-MLK2 were incubated in the presence of Texas Red-labeled transferrin (Fig. 5A ) and examined by fluorescence microscopy. In this assay, transferrin uptake by untransfected cells was characterized by distinct clustering of the fluorochrome into the pericentriolar region typical of recycling endosomes (51) . Cells expressing GFP-MLK2 (arrowheads in Fig. 5A) , however, showed a variable level of clustering with the fluorescent signal mainly present in a fine to course punctate distribution throughout the cell or on the cell surface. To determine the extent of reduction of transferrin uptake into recycling endosomes, cells were transiently transfected with vectors encoding either GFP-MLK2, a kinase-dead MLK2 mutant (GFP-DN-MLK2), or GFP alone. The cells were then incubated with labeled transferrin, and the extent of clustering of the fluorescent signal was quantified as described under "Experimental Procedures." In this analysis (Fig. 5B) , representing data from 100 cells counted from each of 6 independent lots of cells per expression construct, the transferrin uptake was reduced by about 25% in cells overexpressing GFP-MLK2 compared with that of untransfected cells or cells expressing GFP alone. Interestingly, whereas DN-MLK2 binds clathrin equally to wild-type MLK2 (data not shown), overexpression of GFP-DN-MLK2 was not as effective in blocking endocytosis as the wild-type GFP-MLK2 protein.
DISCUSSION
MLK2 and Clathrin Function-We have shown that MLK2 binds clathrin, is enriched in CCVs, and overexpression of MLK2 in cultured cells influences endocytosis. These findings suggest a role for MLK2 and the stress-signaling pathway in clathrin-mediated vesicle trafficking. Clathrin is the major component of the protein layer that coats endocytic vesicles at the plasma membrane and transport vesicles at the trans-Golgi or endosomes (reviewed in Ref. 52 ). The mature clathrin molecule is a heterohexamer of three heavy and three light chains forming a three-legged structure called a triskelion (53) . Together with APs, clathrin triskelia assemble into a polyhedral lattice that shapes the vesicle as it invaginates and buds from the membrane surface. Once formed, the neck of the vesicle is surrounded by a coil-like structure consisting of multimers of the GTPase, dynamin, activation of which is thought to constrict the coil and "pinch" the vesicle away from the surface (e.g. Ref. 54 ). After vesicle release, the clathrin lattice is uncoupled, and the uncoated vesicle is transported by motor proteins along microtubules to various cellular compartments.
Clathrin lattices resembling intracellular vesicle coats will form in vitro when purified clathrin triskelia and APs are mixed under suitable buffer conditions (55) . In vivo, however, a large number of accessory proteins contribute to clathrin coat formation (47) , and many of these are associated with CCVs in vivo. Interestingly, we found the extent of enrichment of endogenous MLK2 in mouse brain CCVs to be comparable with that of clathrin (Fig. 4B) , whereas accessory proteins such as amphiphysin and epsin do not show similar enrichment in CCVs (48, 56) . This suggests that MLK2 is a significant component of CCV protein in the brain.
APs, as well as many accessory proteins, bind through their clathrin box motifs to a site on the CHC N-terminal domain (reviewed in Ref. 47 ) that is directly involved in clathrin coat assembly (57) . As MLK2 also binds CHC through a clathrin box motif, this binding is likely to target the same site. Therefore, reduction of transferrin uptake into recycling vesicles in cells overexpressing MLK2 may reflect competition between MLK2 and APs or accessory protein(s) required for lattice formation. In receptor-mediated endocytosis, such competition between a signaling kinase and accessory proteins for clathrin assembly points could provide a mechanism to tie initiation of clathrin lattice formation to activation of downstream targets in signaling pathways.
DN-MLK2 did not inhibit transferrin uptake as strongly as the wild-type protein (Fig. 5B) , indicating that MLK2 catalytic activity, as well as the clathrin binding, is involved in the observed effect on vesicle trafficking. MLK2 is a MAP3K whose only known substrates are MKK4 and MKK7, direct activators of JNK in the stress-activated signaling cascade (5). To our knowledge, mitogen-activated protein kinase cascade members have not been reported previously among clathrin-binding proteins; however, recent data (33, 58 -60) have begun to link intracellular signaling pathways with regulation of vesicle trafficking. In particular, recruitment of the MLK-JNK scaffold, JIP, to apoER2 (32) , and interaction of an apoER2-JIP-DLKkinesin complex with microtubules raise the possibility that this JNK signaling module regulates vesicle movement or recycling of trafficking components at vesicle destinations (33) . Activation of the JNK cascade by MLK2 or other MAP3Ks during clathrin lattice formation or uncoupling may contribute to such regulation.
MLK2-binding Partners and Vesicle
Trafficking-It is now becoming clear that many cellular processes require the formation of multiprotein complexes at specific sites of activity within the cell. Therefore, it is worthy of note that clathrin joins a significant group of MLK2-binding partners with documented roles in vesicle formation or transport. For instance, the MLK2-SH3 domain binds dynamin and synergizes with phospholipids to accelerate dynamin GTPase activity (23) , vital for release of vesicles from membrane surfaces (reviewed in Ref. 59 ). 14.3.3 proteins have been implicated in regulation of vesicle trafficking in yeast (60) , and the MLK2-CRIB motifbinding partners, Cdc42 and Rac, although primarily known as regulators of actin rearrangement at the cell surface (29) , both have clearly identified roles in vesicle formation and/or movement (26 -28) . In this respect, it is interesting that ACK2, another SH3 domain containing kinase that binds Cdc42 through a CRIB motif and is highly expressed in brain, is also a clathrin-binding protein (61, 62) . ACK2 binds clathrin through a clathrin box motif and influences clathrin-mediated endocytosis in a similar way to MLK2 (62) . Therefore, ACK2 and MLK2 may contribute to linking Cdc42 and/or Rac to clathrin function in vesicle trafficking.
MLK2 also interacts with huntingtin (35), a protein known mainly for its involvement in the neurodegeneration associated with Huntington's disease. Whereas the normal function of huntingtin is not well understood, it is widely distributed in mammalian cells suggesting a role in general cellular processes (63) . Huntingtin associates with vesicle membranes and microtubules (63) (64) and accumulates at sites of nerve ligation (65) , characteristics compatible with a role in vesicular trafficking or axonal transport. Furthermore, a group of huntingtin-interacting proteins, HIP1, HIP1R and HIP12, are mammalian homologues of Sla2p, an actin-binding protein important for cytoskeletal assembly and endocytosis in yeast (66) . HIP1 binds clathrin through a clathrin box motif (Fig. 3C ) and interacts with AP-2 (67, 68) , and all three HIPs function in endocytosis (67, 69, 70) .
Further interactions that link MLK2 to vesicle trafficking are with PSD-95 (22), a scaffold protein with roles in both endocytosis and downstream signaling (reviewed in Ref. 24 and see Ref. 71) , and with kinesin-family motor proteins (20) . MLK2 binds both the neuronal plus-end microtubule motor, KIF3, and its targeting component, KAP3A (20) . KIF3 transports fodrin-associated vesicles in neurons and is required for both fast axonal transport and neurite outgrowth (72) , whereas KAP3A recruits cargo to the motor protein complex (72, 73) . Interaction with clathrin as well as KAP3A implicates MLK2 in targeting of specific cargo at vesicle formation sites and/or transmission of signals downstream from activated cargo components. In addition to clathrin and two distinct subunits of the motor complex, MLK2 binds JIP and JIP binds kinesin light chains as well as cargo components (33, 34) . It is not clear if these interactions are regulatory or merely a molecular glue to stabilize motor protein-signaling cascade-vesicle complexes during transport. As MLK2 is enriched in CCVs and interacts with a diverse range of proteins associated with vesicle traf-ficking, it would seem likely that it is involved in protein complexes that regulate endocytic function. It will now be of interest to dissect MLK2 complexes under various conditions of cellular activation to determine the role of its myriad interactions in intracellular transport.
